Ameren CorporationAEE
NYSE • Utilities
$115.10
P/E
21.52
PEG
0.01
FCF Yield
—
Rev Growth YoY
+1543.0% YoY
Gross Margin
4339.1%
Health Score
4/10
D/E Ratio
1.48
Confidence
LOW
Business Snapshot
Ameren Corporation is a regulated electric and natural gas utility serving approximately 2.4 million electric and 900,000 natural gas customers across Missouri and Illinois. The company operates within the tightly regulated utility sector, where earnings visibility tends to be high but growth is structurally modest. Based on the available valuation ratios and price data, Ameren is best characterised as a large-cap utility, though the precise market capitalisation figure is not available in this data set.
Financial Health
Score: 4/10
The financial health picture for Ameren is complicated by several data anomalies. The gross margin of 4,339.1% and net margin of 1,655.0% are almost certainly the result of a data normalisation or reporting artefact — margins of this magnitude are not operationally meaningful for a regulated utility and should be treated with significant scepticism...
Risk Assessment
- DATA INTEGRITY: Reported gross margin of 4,339.1%, net margin of 1,655.0%, revenue growth of 1,543.0%, and earnings growth of 2,100.0% are almost certainly data artefacts — not genuine operating metrics — and materially undermine the reliability of this entire data payload.
- LIQUIDITY: Current ratio of 0.66x indicates short-term liabilities exceed short-term assets, leaving limited buffer against near-term financial stress.
- CASH FLOW OPACITY: Free cash flow is listed as N/A, making it impossible to assess dividend sustainability or capital expenditure funding capacity — critical metrics for a utility investor.
- TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates negative medium-term price momentum.
- EARNINGS CONSISTENCY: Only 2 of the last 4 quarters beat analyst estimates, suggesting limited earnings predictability despite the regulated business model.
---...
**Score: 4/10** The financial health picture for Ameren is complicated by several data anomalies. The gross margin of 4,339.1% and net margin of 1,655.0% are almost certainly the result of a data normalisation or reporting artefact — margins of this magnitude are not operationally meaningful for a regulated utility and should be treated with significant scepticism. Debt/equity of 1.48x is elevated but not unusual for a capital-intensive utility business, which routinely carries significant long-term debt to fund infrastructure. However, the current ratio of 0.66x signals that short-term liabilities exceed short-term assets, indicating limited near-term liquidity buffer, and the absence of free cash flow data prevents a full assessment of the company's ability to fund dividends and capital expenditure. ---
- **DATA INTEGRITY:** Reported gross margin of 4,339.1%, net margin of 1,655.0%, revenue growth of 1,543.0%, and earnings growth of 2,100.0% are almost certainly data artefacts — not genuine operating metrics — and materially undermine the reliability of this entire data payload. - **LIQUIDITY:** Current ratio of 0.66x indicates short-term liabilities exceed short-term assets, leaving limited buffer against near-term financial stress. - **CASH FLOW OPACITY:** Free cash flow is listed as N/A, making it impossible to assess dividend sustainability or capital expenditure funding capacity — critical metrics for a utility investor. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates negative medium-term price momentum. - **EARNINGS CONSISTENCY:** Only 2 of the last 4 quarters beat analyst estimates, suggesting limited earnings predictability despite the regulated business model. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives